Original Research
Accepted on 10 Feb 2025
Guselkumab binding to CD64 + IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling
in Cytokines and Soluble Mediators in Immunity
Original Research
Accepted on 10 Feb 2025
in Cytokines and Soluble Mediators in Immunity
Case Report
Accepted on 10 Feb 2025
in Genitourinary Oncology
Review
Accepted on 10 Feb 2025
in Ocean Solutions
Original Research
Accepted on 10 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 10 Feb 2025
in Alzheimer's Disease and Related Dementias
Original Research
Accepted on 10 Feb 2025
in Genitourinary Oncology
Editorial
Accepted on 10 Feb 2025
in Microbial Symbioses
Original Research
Accepted on 10 Feb 2025
in Nutrition and Metabolism
Original Research
Accepted on 10 Feb 2025
in Gastrointestinal and Hepatic Pharmacology
Mini Review
Accepted on 10 Feb 2025
in Perception
Review
Accepted on 10 Feb 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 10 Feb 2025
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 10 Feb 2025
in Quantitative Psychology and Measurement
Original Research
Accepted on 10 Feb 2025
in Cardiac Rhythmology
Original Research
Accepted on 10 Feb 2025
in Alzheimer's Disease and Related Dementias
Systematic Review
Accepted on 10 Feb 2025
in Pediatric Surgery